Skip to main content
. 2025 Jan 17;12(2):e200367. doi: 10.1212/NXI.0000000000200367

Figure 4. Comparative MCP-Counter Deconvolution Between Ri-PNS, Yo-PNS, and Control BCs.

Figure 4

Boxplots of the median value and interquartile range (IQR) for the concerned variable of control luminal B BC (on the left, in blue) and Ri-PNS BC (on the right, in green) samples (A) or Ri-PNS BCs (on the left, in green) and Yo-PNS BCs (on the right, in orange) (B); the upper whisker extends from the hinge to the largest value no further than 1.5 × IQR, and the lower whisker extends to the smallest value to a maximum of 1.5 × IQR from the hinge; each dot represents the value of a sample. p values of comparisons between groups using the Wilcoxon rank-sum test are adjusted with the Benjamini and Hochberg method (details in eMethods) and shown on the top of each couple of boxplots. Ri-PNS and Yo-PNS samples from metastatic lymph nodes were removed. (A) Comparison of selected signatures between Ri-PNS and control luminal B BCs. (B) Comparison of selected signatures between Yo-PNS and Ri-PNS BCs. BC = breast cancer; MCP = Microenvironment Cell Populations; Ri-PNS = paraneoplastic neurologic syndrome and anti-Ri antibodies; Yo-PNS = paraneoplastic neurologic syndrome and anti-Yo antibodies.